Effects of α-lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Microglial cells are known as the main immune cells in the central nervous system, both regulating its immune response and maintaining its homeostasis. Furthermore, the antioxidant α-lipoic acid (LA) is a recognized therapeutic drug for diabetes because it can easily invade the blood–brain barrier. This study investigated the effect of α-LA on the inflammatory response in lipopolysaccharide (LPS)-treated BV-2 microglial cells. Our results revealed that α-LA significantly attenuated several inflammatory responses in BV-2 microglial cells, including pro-inflammatory cytokines, such as tumor necrosis factor-α and interleukin (IL)-6, and other cytotoxic molecules, such as nitric oxide and reactive oxygen species. In addition, α-LA inhibited the LPS-induced phosphorylation of ERK and p38 and its pharmacological properties were facilitated via the inhibition of the nuclear factor kappa B signaling pathway. Moreover, α-LA suppressed the activation of NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasomes, multiprotein complexes consisting of NLRP3 and caspase-1, which are involved in the innate immune response. Finally, α-LA decreased the genes accountable for the M1 phenotype, IL-1β and ICAM1, whereas it increased the genes responsible for the M2 phenotype, MRC1 and ARG1. These findings suggest that α-LA alleviates the neuroinflammatory response by regulating microglial polarization.
Abstract
Microglial cells are known as the main immune cells in the central nervous system, both regulating its immune response and maintaining its homeostasis. Furthermore, the antioxidant α-lipoic acid (LA) is a recognized therapeutic drug for diabetes because it can easily invade the blood–brain barrier. This study investigated the effect of α-LA on the inflammatory response in lipopolysaccharide (LPS)-treated BV-2 microglial cells. Our results revealed that α-LA significantly attenuated several inflammatory responses in BV-2 microglial cells, including pro-inflammatory cytokines, such as tumor necrosis factor-α and interleukin (IL)-6, and other cytotoxic molecules, such as nitric oxide and reactive oxygen species. In addition, α-LA inhibited the LPS-induced phosphorylation of ERK and p38 and its pharmacological properties were facilitated via the inhibition of the nuclear factor kappa B signaling pathway. Moreover, α-LA suppressed the activation of NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasomes, multiprotein complexes consisting of NLRP3 and caspase-1, which are involved in the innate immune response. Finally, α-LA decreased the genes accountable for the M1 phenotype, IL-1β and ICAM1, whereas it increased the genes responsible for the M2 phenotype, MRC1 and ARG1. These findings suggest that α-LA alleviates the neuroinflammatory response by regulating microglial polarization.
참고문헌 (23)
- Shi H, "Kruppel-like factor 2protects against ischemic stroke by regulating endothelial blood brain barrier function", Am J Physiol Heart Circ Physiol, 304, pp.H796~H805 (2013)
- Cunha C, "Exploring new inflammatory biomarkers and pathways during LPS-Induced M1 polarization", Mediators Inflamm, 2016, pp.6986175~ (2016)
- Orihuela R, "Microglial M1", M2 polarization and metabolic states, 2016, pp.173, 649~665
- Bauernfeind FG, "NF-kB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression", J Immunol, 183, pp.787~791 (2010)
- Jo EK, "Molecular mechanisms regulating NLRP3 inflammasome activation", Cell Mol Immunol, 13, pp.148~159 (2016)
- Thirunavukkarasu V, "Lipoic acid attenuates hypertension and improves insulin sensitivity, kallikrein activity and nitrite levels in high fructose-fed rats", J Comp Physiol B, 174, pp.587~592 (2004)
- Kamenova P, "Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid", Hormones (Athens), 5, pp.251~258 (2006)
- Maczurek AE, "Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer’s disease", Adv Nat Med Nutraceuticals Neurocognition, 60, pp.71~88 (2013)
- Brown GC, "How microglia kill neurons", Brain Res, 1628, pp.288~297 (2015)
- Qureshi GA, "Neurotoxicity, oxidative stress and cerebrovascular disorders", Neurotoxicology, 25, pp.121~138 (2004)
- Chen L, "NLRP3inflammasome activation by mitochondrial reactive oxygen species plays a key role in long-term cognitive impairment induced by paraquat exposure", Neurobiol Aging, 36, pp.2533~2543 (2015)
- Chew LJ, "Microglia and inflammation : impact on developmental brain injuries", Ment Retard Dev Disabil Res Rev, 12, pp.105~112 (2006)
- Sorbara MT, "Mitochondrial ROS fuel the inflammasome", Cell Res, 21, pp.558~560 (2011)
- Yang JW, "3-(Naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride attenuates NLRP3 inflammasome-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglial cells", Biochem Biophys Res Commun, 495, pp.151~156 (2018)
- Walsh JG, "Inflammasome in the CNS", Nat Rev Neuroeci, 15, pp.84~97 (2014)
- Fan HH, "Hyperoside inhibits lipopolysaccharide-induced inflammatory responses in microglial cells via p38 and NFB pathways", Int Immunopharmacol, 50, pp.14~21 (2017)
- Yang XW, "Safflower Yellow regulates microglial polarization and inhibits inflammatory response in LPS-stimulated Bv2 cells", Int J Immunopathol Pharmacol, 29, pp.54~64 (2016)
- Kim EA, "Anti-inflammatory mechanisms of N-adamantyl-4-methylthiazol-2-amine in lipopolysaccharide-stimulated BV-2 microglial cells", Int Immunopharmacol, 22, pp.73~83 (2014)
- Heneka MT, "Neuroinflammation in Alzheimer’s disease", Lancet Neurol, 14, pp.388~405 (2015)
- Tremblay MÈ, "Microglia in health and disease", Microglia Heal Dis, 313, pp.1~486 (2014)
- 김승현, "Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases", BMB Reports, 51(11), pp.545~546 (2018), 생화학분자생물학회
- Samstad EO, "Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release", J Immunol, 192, pp.2837~2845 (2014)
- 양승주, "Anti-inflammatory and anti-oxidative effects of 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride on β-amyloid-induced microglial activation", BMB Reports, 50(12), pp.634~639 (2017), 생화학분자생물학회
